| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,337 |
3,991 |
$2.03M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,345 |
7,036 |
$905K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
584 |
508 |
$161K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,114 |
1,004 |
$66K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,590 |
5,947 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
997 |
961 |
$56K |
| 80053 |
Comprehensive metabolic panel |
3,459 |
3,141 |
$44K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
943 |
845 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
783 |
693 |
$20K |
| 87400 |
|
551 |
302 |
$10K |
| 81001 |
|
2,019 |
1,870 |
$7K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
940 |
888 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
608 |
546 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
239 |
220 |
$5K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
56 |
54 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
131 |
114 |
$4K |
| 84484 |
|
750 |
537 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
15 |
14 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
129 |
123 |
$3K |
| 83690 |
|
208 |
193 |
$1K |
| 87807 |
|
67 |
65 |
$1K |
| 84703 |
|
127 |
117 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
54 |
49 |
$864.47 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17 |
13 |
$620.49 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
208 |
172 |
$559.52 |
| 83735 |
|
98 |
86 |
$547.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
55 |
53 |
$381.72 |
| 83880 |
|
39 |
38 |
$361.13 |
| 81025 |
|
20 |
17 |
$350.68 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
110 |
103 |
$185.02 |
| 36415 |
Collection of venous blood by venipuncture |
3,858 |
3,419 |
$178.47 |
| 84702 |
|
14 |
13 |
$176.96 |
| 80076 |
|
15 |
15 |
$151.35 |
| 85610 |
|
76 |
65 |
$68.41 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
54 |
39 |
$62.19 |
| 85730 |
|
26 |
24 |
$34.35 |
| A9270 |
Non-covered item or service |
5,290 |
3,618 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
46 |
41 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
15 |
15 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
14 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
84 |
72 |
$0.00 |